🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 19 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/09/2003 35,40 36,24 34,26 35,16 -2,17% 5,59% 72.650
18/09/2003 37,20 37,44 34,92 35,94 +7,73% 6,77% 376.167
17/09/2003 32,76 34,02 32,46 33,36 +2,02% 4,76% 50.500
16/09/2003 31,62 33,30 31,20 32,70 +2,44% 6,64% 46.850
15/09/2003 32,58 32,58 31,20 31,92 +0,57% 4,24% 25.433
12/09/2003 31,68 32,46 31,32 31,74 -0,56% 3,60% 38.133
11/09/2003 32,82 32,88 31,68 31,92 -1,12% 3,66% 48.300
10/09/2003 34,62 35,10 32,10 32,28 +0,19% 8,67% 136.967
09/09/2003 32,16 33,12 31,68 32,22 -0,56% 4,48% 48.183
08/09/2003 30,06 32,70 30,06 32,40 +1,69% 8,78% 78.783
05/09/2003 33,06 33,30 31,80 31,86 -5,01% 4,54% 64.800
04/09/2003 34,38 34,56 32,52 33,54 +1,64% 5,93% 76.483
03/09/2003 33,06 34,20 32,46 33,00 -0,18% 5,26% 60.517
02/09/2003 33,36 34,32 31,80 33,06 -0,54% 7,55% 75.700
29/08/2003 31,62 33,78 31,62 33,24 +5,32% 6,83% 61.750
28/08/2003 30,24 31,56 29,82 31,56 +4,78% 5,75% 59.950
27/08/2003 29,58 30,24 28,80 30,12 +1,21% 4,87% 33.450
26/08/2003 29,64 30,60 28,50 29,76 +0,61% 7,09% 56.433
25/08/2003 28,26 29,64 27,60 29,58 +4,89% 7,22% 41.933
22/08/2003 28,80 29,40 28,20 28,20 -2,69% 4,17% 27.950
21/08/2003 27,60 29,22 27,60 28,98 +5,69% 5,87% 52.133
20/08/2003 27,78 27,78 26,52 27,42 -0,65% 4,54% 33.933
19/08/2003 27,78 28,14 26,52 27,60 +0,44% 5,83% 41.917
18/08/2003 28,14 28,14 26,94 27,48 -0,43% 4,26% 28.933
15/08/2003 27,54 28,50 27,06 27,60 +1,10% 5,23% 22.017
14/08/2003 28,98 29,10 27,00 27,30 +0,89% 7,25% 90.967
13/08/2003 26,46 27,06 25,86 27,06 +4,64% 4,54% 52.867
12/08/2003 28,20 28,68 25,86 25,86 -8,30% 10,00% 89.433
11/08/2003 29,52 29,70 27,36 28,20 -5,43% 7,93% 60.383
08/08/2003 30,24 30,84 29,70 29,82 -0,60% 3,77% 19.283